29 April 2014
Scientists that have been examining cancerous tumour tissues believe they have identified a new strategy that could potentially treat ovarian cancer, according to the University of Manchester.
The NHS states that this particular form of the disease affects over 6,500 women every year in the UK and is the fifth most common cancer among the female population. As many are often diagnosed at later stages, prognosis is poor.
Recently developed drugs that target a tumour’s blood supply have increased survival rates, but patients can develop a resistance to such therapies.
Now, a team of researchers from the university claim that by simultaneously blocking “several avenues” cancerous cells often use to escape being destroyed, the treatment will be more effective.
Professor Gordon Jayson, lead author of the study, said: “Targeting multiple factors and blocking several avenues that tumour cells use to escape eradication at the same time may be a better strategy than current drugs, which target only one molecule.”
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.